MiMedx集团股份有限公司2025年季度报告

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For theQuarterly Period EndedSeptember 30, 2025 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________________to______________________ Commission File Number001-35887MIMEDX GROUP, INC. (Exact name of registrant as specified in its charter) 26-2792552 (I.R.S. Employer Identification No.) (Zip Code) (770)651-9100(Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Name of each exchange on whichregistered Securities registered pursuant to Section 12(g) of the Act: None. Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the SecuritiesExchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports),and (2) has been subject to such filing requirements for the past 90 days.Yesx No¨ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submittedpursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that theregistrant was required to submit such files).Yesx No¨ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smallerreporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reportingcompany,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filerxAccelerated filer¨Non-accelerated filer¨Smaller reportingcompany☐Emerging growthcompany☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period forcomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.¨ Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).Yes☐Nox There were148,102,159shares of the registrant’s common stock, par value $0.001 per share, outstanding as of October20, 2025. Explanatory Note and Important Cautionary Statement Regarding Forward-Looking Statements As used herein, the terms “MIMEDX,” the “Company,” “we,” “our” and “us” refer to MiMedx Group, Inc., a Florida corporation, andits consolidated subsidiaries as a combined entity, except where it is clear that the terms mean only MiMedx Group, Inc. Certain statements made in this Quarterly Report on Form 10-Q (this “Quarterly Report”) are “forward-looking statements” within themeaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and section 21E of the Securities ExchangeAct of 1934, as amended. All statements herein relating to events or results that may occur in the future are forward-lookingstatements, including, without limitation, statements regarding the following: •our strategic focus and current business priorities, including broadening of our product portfolio, and our ability to implementthese priorities;•our expectations regarding costs relating to compliance with regulatory requirements;•our expectations regarding capital allocation;•our expectations regarding future growth;•our expectations regarding the outcome of pending litigation and investigations;•our expectations regarding future income tax liability;•demographic and market trends; and•our ability to compete effectively. Forward-looking statements generally can be identified by words such as “expect,” “will,” “change,” “intend,” “seek,” “target,”“future,” “plan,” “continue,” “potential,” “possible,” “could,” “estimate,” “may,” “anticipate,” “to be” and similar expressions. Thesestatements are based on numerous assumptions and involve known and unknown risks, uncertainties and other factors that couldsignificantly affect the Company’s operations and may cause the Company’s actual actions, results, financial condition, performanceor achievements to differ materially from any future actions, results, financial condition, performance or achievements expressed orimplied by any such forward-looking statements. Factors that may cause such a difference include, without limitation, those discussedunder the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024 (our “2024 Form 10-K”), filed with the Securities and Exchange Commission (“SEC”) on February 26, 2025 and those discussed in Part II, Item 1A, RiskFactors, if any. Unless required by law, the Company does not intend, and undertakes no obligation, to update or publicly release any revision to anyforward-looking statements, whether as a result of the receipt of new information, the occurrence of subsequent events, a change incircumsta